MANAGING SUPPLY CHAIN RISK, SECURITY & INTEGRITY IN VOLATILE ENVIRONMENTS

8:30 Registration and coffee Registration and coffee

8:50 Chairperson's welcome and opening remarks Chairperson's welcome and opening remarks

9:00 Opening Keynote Address: Coming late to the party: The need for a proactive, holistic approach to supply chain risk and integrity within the pharmaceutical industry Viliam Kovac, Vice President Global Supply Chain Quality, Roche The importance of knowing where current and risks are coming from Where the supply chain is most vulnerable and where this will rapidly change Creating an internal mind-set capable of rapidly addressing and mitigating these risks Linking security with patient health Ensuring the quality of an increasingly outsourced and virtual supply chain What level of control we need to maintain The complexity question and link to external influences Tools and processes to support this journey Viliam Kovac Vice President Global Supply Chain Quality, Roche Vice President of Global Supply Chain Quality at Roche Diagnostics based in Mannheim, Germany. Holding two University Degrees in Economics (International Trade & Business Management). With global responsibility he provides competent expertise in Business and Quality & Regulatory subjects across the International Supply Chain Operations, including Material Flow Plann [read more]

9:30 Case study presentation: The road to establishing a global supply chain integrity organisation: developing optimal strategies for risk mitigation, network development and unpredictability Stephan Gotthardt, Corporate Vice President Supply Chain Management, Boehringer Ingelheim Defining the scope and focus of a global integrity organisation Serialisation & RFID Track and Trace Adulteration Defining the right trade-off between acceptable risk and unacceptable risk Balancing cost vs. benefits Controlling the designed-in risk What constitutes best contingency plan practice and the importance of a truly global supply chain view Integrity and risk in emerging markets Managing the complexity by harmonising systems and leveraging opportunities Stephan Gotthardt Corporate Vice President Supply Chain Management, Boehringer Ingelheim

10:00 Keynote: Risk management as an opportunity rather than a burden: linking systems to provide global visibility and developing the right thought processes and tools necessary to support this Claude Laurent, VP, Supply Chain & Manufacturing, Astellas Pharma Designing and implementing a structured approach to risk management and assessing the right tools, processes and software designed to support this How is risk management carried out in practice? Opportunities to harness additional regulatory requirements to increase supply chain visibility and optimisation Double sourcing and network design to ensure flexibility and mitigate risk Inventory level optimisation – setting the right target Areas where the organisation will benefit on both bottom line and strategic indicators Issue detection earlier Safeguarding continuity Enhanced compliance Linking systems together with operations, inventory planning and S&OP processes Driving true differentiation and a competitive advantage Claude Laurent VP, Supply Chain & Manufacturing, Astellas Pharma

Morning refreshments and networkingSpeaker’s corner 10:30 Morning refreshments and networking Morning refreshments and networking Morning refreshments and networking 10:30 Speaker’s corner Speaker’s corner During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly about any questions not covered during their session.

11:00 Panel Discussion: The case for traceability: how far have we come, how far from practical implementation are we, the state-of-the-art technology behind this and what you need to know to be prepared now Hans-Walter Hoehl, VP of Strategy & Projects, Bayer HealthCare Sebastien Mauel, Head of Global Product Security, Merck Serono Arjan Adegeest, Executive Director Supply Chain, Alexion Pharma Aurelien Commeureuc, Competitive Intelligence and Marketing Manager, SICPA François Bouvy, Director, Team Leader – ESPC Lead, EFPIA Jyrki Syvari, Director of Supply Chain Integrity, Boehringer Ingelheim Worldwide regulatory updates and directions How the falsified medicines directive will impact on your business FDA announcements The rapid emerging market environment evolution System architecture and design Why those who approach this issue with a ‘wait and see’ attitude will be left behind Serialisation – it’s not so simple Guidance and best practices to ensure compliance Length of time required for implementation RFID – will it ever be ready for practical use in wider pharma applications? Building the required infrastructure Ensuring cost effectiveness Hans-Walter Hoehl VP of Strategy & Projects, Bayer HealthCare Hans-Walter Hoehl became VP of Strategy & Projects at Bayer HealthCare Global Pharmaceutical Production in January 2011. He is responsible for defining the manufacturing strategy and executing key projects to optimize the operational and financial performance of BHC Pharmaceuticals’ five supply centers and twelve regional manufacturing sites. He leads a team of operational excellen [read more] Sebastien Mauel Head of Global Product Security, Merck Serono Arjan Adegeest Executive Director Supply Chain, Alexion Pharma Arjan is executive Director Supply Chain at Alexion Pharma International. He leads a team of 5 persons and managers, excluding several Supply Chain managers in the regions. Arjan’s major challenges for 2012 is to roll-out full traceability capabilities in the EU AND other more sensitive regions, as well as implementing a strong Risk Mitigation Action Plan. He hopes to meet likeminded professionals [read more] Aurelien Commeureuc Competitive Intelligence and Marketing Manager, SICPA François Bouvy Director, Team Leader – ESPC Lead, EFPIA Jyrki Syvari Director of Supply Chain Integrity, Boehringer Ingelheim Jyrki Syväri, Pharmacist and Chemist, made his PhD Theses in Pharmaceutical Chemistry and his Diploma in Chemistry in Analytical Chemistry. He joined Schering AG in Berlin and headed there a R&D Laboratory for the development of parenteral drugs. He left Schering AG to join Boehringer Ingelheim (corporate headquarters), where he became a Project Manager in Operations. He was respon [read more]

11:40 Case study presentation: Examining the EFPIA path towards coding, serialisation and identification in Germany: Aligning all stakeholders behind a common goal and what this means for EU-wide adoption Hans-Walter Hoehl, VP of Strategy & Projects, Bayer HealthCare Pilot project background and history – what hurdles did we face and how did we get here? Defining and negotiating the coding specifications for one standardised identification solution Importance of partner selection and ensuring the right capabilities exist Moving from strategy to implementation and gaining alignment What this means for broad, global implementation Hans-Walter Hoehl VP of Strategy & Projects, Bayer HealthCare Hans-Walter Hoehl became VP of Strategy & Projects at Bayer HealthCare Global Pharmaceutical Production in January 2011. He is responsible for defining the manufacturing strategy and executing key projects to optimize the operational and financial performance of BHC Pharmaceuticals’ five supply centers and twelve regional manufacturing sites. He leads a team of operational excellen [read more]

12:10 360 degree supply chain security: The new approaches to emerging global threats Stuart Anderson, Head of Global Supply Chain Enabling Capabilities, AstraZeneca Achieving a resilient supply chain that is both agile and secure – a universal, cross sector approach Investigating the falsified medicine supply chain The risk:reward balance and motivation Addressing the economics Emerging areas of security risk – it’s not just the counterfeiters Thefts and armed robberies Large-scale diversion Genuine product ‘leakage’ The role of the regulators and establishing the right relationship No one single magic bullet - the technologies necessary to combat the counterfeiters Standardisation and pack features Delayed printing strategies Where can we as an industry improve? Open sharing and collaboration as a solution Promoting strategy and collaboration Stuart Anderson Head of Global Supply Chain Enabling Capabilities, AstraZeneca Stuart Anderson achieved his degrees in Chemical Engineering and Pharmacy at Sydney University. He joined Astra Pharmaceuticals as a Process Engineer in 1987 and subsequently held a number of roles in Production Management, Technical Management, QA and Development. In 1997, Stuart became the site lead and Manufacturing Director at Astra in Sydney. In 2000, he moved into the commercial operations f [read more]

Networking luncheonSpeaker's corner 12:40 Networking luncheon Networking luncheon Networking luncheon 12:40 Speaker's corner Speaker's corner During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly about any questions not covered during their session.

13:30 Optimising cold chain transport security solutions Ralf Schneider, Pharmacuetical Logistics Director, Groep H Essers Ron van Holland, Business Unit Manager, Security Logistics, Groep H Essers Optimising cold chain transport security solutions Ralf Schneider Pharmacuetical Logistics Director, Groep H Essers Ron van Holland Business Unit Manager, Security Logistics, Groep H Essers

14:00 Out of industry case study: Re-engineering a state of the art supply chain security blueprint, driven by close industry collaborations Salvatore Paparelli, CEO, Sony Italy Out of industry case study: Re-engineering a state of the art supply chain security blueprint, driven by close industry collaborations Salvatore Paparelli CEO, Sony Italy Salvatore Paparelli joined Sony Italia in 1989 in the Marketing Department. In 1997 he moved to Sony Europe HQ in Cologne to be in charge of Pan European Accounts and later in 1999 he was appointed General Manager of Sales Channel Management Europe in the newly established Sony Berlin HQ. In 2002 he took over the responsibility of European Sales of Consumer product in the function of Director, unt [read more]

14:30 Mitigating the risks across distribution networks in emerging markets Zoltan Menyhart, COO, Cemelog Setting the right standards Ensuring regional partners meet quality and compliance requirements for a high-quality product Best in class approaches to qualification and standard setting Driving an effective and realistic process planning function Zoltan Menyhart COO, Cemelog After completing his university studies in Economics in Baltimore (US), Mr. Menyhárt had worked for Allegis group (the largest privately held staffing firm in the US) in various junior positions in the Business Development area. Utilizing his international experience, he gained expertise in the HR part of the SCM field. Accepting a position in his home country of Hungary as the SCM Manager of a Hu [read more]

Afternoon coffee & networkingSpeaker's corner 15:00 Afternoon coffee & networking Afternoon coffee & networking Afternoon coffee & networking 15:00 Speaker's corner Speaker's corner During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly about any questions not covered during their session.

15:30 Interactive breakout session: Who is stealing your profit? Fool-proofing your supply chain to stay ahead of the counterfeiters Ann Merchant, President, Schreiner MediPharm What approach to take to combat the counterfeiters The need for continuous improvement and evolution Combining various technologies and tactics to give you the edge Developing an effective framework of tools at your disposal Integrity - proof of tampering Origin - track and trace Originality - authentication and verification Illustrative case studies and investigations into counterfeiting Practical and strategic take-home messages to drive immediate improvements Ann Merchant President, Schreiner MediPharm Ann Merchant is President of Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich in Germany. Schreiner MediPharm develops and produces innovative, multi-functional specialty labels with value-added benefits for the pharmaceutical industry. Ann is responsible for the sales organization, global strategy and further development of the business unit building o [read more]

16:30 Interactive breakout session: Working Collaboratively with outsourcing partners to maximise capabilities and returns Harald Augustin, Head of Steinbeis-Transfer Centre, ESB Business School Outsourcing has traditionally been seen as driver towards lowering bottom-line costs, with any business improvements coming in as a distant afterthought. However more and more BioPharma and Generics firms now realise that effective collaboration is where the battle for excellence is won or lost, and that by working collaboratively with outsourcing partners, rather than just driving for cost reduction, they’re able to liberate real improvements. Working collaboratively doesn’t just mean signing a contract and meeting after two years to see it potentially hasn’t worked. Partners must work hard to forge these effectively relationships– this takes time, effort and proactive management. This interactive workshop addresses the new paradigm of outsourcing relationships and delivers a comprehensive tool-box enabling you to make immediate improvements to your strategy and execution of value-generating partnerships. Educating the value chain to ensure responsibility and ownership at each step Synchronising the actions of all the players in the supply chain to achieve objectives Collaborative planning Technology enabling better visibility and relationship management How best to utilise service level agreements to benefit both parties and define the relationship from all points of view Agreeing and defining responsibilities, KPI’s and service levels Strategic considerations Emplacing and empowering the right people to ensure best relationship management Optimising IT components and links between organisations The tools available to facilitate open and optimised communication Aligning benefits for both parties The devil in the details – accessing the right data at the right time Case study examples: Spotting and addressing specific red flags Harald Augustin Head of Steinbeis-Transfer Centre, ESB Business School Prof. Dr.-Ing. Harald Augustin is Deputy Dean, Vice Dean for Corporate Relations & Alumni, Buildings & IT and professor at the ESB Business School, Reutlingen University. His fields of research and teaching are supply chain management, logistics engineering and supply chain management, Lean Warehousing, Green Warehousing, factory planning and the Digital Factory as [read more]

17:10 Interactive breakout session: Getting the best out of innovative network systems by optimal talent management and development Developing a talent pipeline to meet the pharma’s current and future needs is one of the most pressing challenges facing SC management. Nowhere is this challenge more visible than in the emerging markets, where most business are trying to upscale their organisation and are struggling to attract and retain people capability. This workshop addresses several high level perspectives on how SC leaders are pushing human capital efforts internally within the SC, rather than leaving this key function to the traditional HR route. Crucial requirements to develop human capital Building flexibility and redundancy into organisational structure by training people to be multi-skilled Practical skills and SC expertise Special SC needs Cultural and language needs SC management leader development – key capabilities Global perspective of regional and corporate culture Technical capabilities Cross-functional, relational leadership and communication Developing the right solution for talent-resilient supply chain organisation Combating the high competition for talented professionals in these regions Overcoming the profession’s low profile Professional accreditation Exploiting web-based training On-going education, retention strategies and incentives Exporting talent to emerging regions without leaving a gap in established region capability

17:40 Chairperson's summary & end of focus day Chairperson's summary & end of focus day

17:50 LogiPharma Europe networking drinks reception LogiPharma Europe networking drinks reception

19:30 LogiPharma Pre-Conference Networking Dinner To be hosted by Camelot Management Consultants This invitation-only dinner is solely for manufacturers attending Logipharma to network before the main conference begins. If you are interested in attending, please contact logipharma@wbr.co.uk. Otherwise, you will receive a personal invitation from Camelot Management Consultants.